A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors
Clinical trial NCT05888831 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05888831
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-06
- Primary completion
- 2026-09-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.